1. Search Result
Search Result
Isoforms Recommended: KDM4
Results for "

KDM4B

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

1

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-104048
    QC6352
    Maximum Cited Publications
    11 Publications Verification

    Histone Demethylase Cancer
    QC6352 is an orally active KDM4 inhibitor with anti-tumor and anti-proliferative activity. QC6352 has in vivo inhibitory effects on PDX models of breast and colon cancer and reduces the number of chemoresistant cell populations. QC6352 inhibits KDM4 different isoforms with IC50s of 104 nM (KDM4A), 56 nM (KDM4B), 35 nM (KDM4C), and 104 nM (KDM4D), respectively. QC6352 has moderate inhibitory activity against KDM5 with an IC50 of 750 nM (KDM5B) .
    QC6352
  • HY-12725
    ML324
    5+ Cited Publications

    Histone Demethylase HSV CMV Cancer
    ML324 is a potent JMJD2 demethylase inhibitor with antiviral activity. ML324 also exhibits inhibition for the histone demethylase KDM4B, with an IC50 of 4.9 μM. ML324 has potent anti-viral activity against both herpes simplex virus (HSV) and human cytomegalovirus (hCMV) infection via inhibition viral IE gene expression .
    ML324
  • HY-101799
    NCGC00244536
    2 Publications Verification

    KDM4B Inhibitor B3

    Histone Demethylase Cancer
    NCGC00244536 is a potent KDM4B inhibitor with an IC50 of 10 nM.
    NCGC00244536
  • HY-148807

    QC8222 free base; TACH 101 free base

    Histone Demethylase Apoptosis Cancer
    Zavondemstat (QC8222 free base; TACH 101 free base) is an orally active pan-KDM4 inhibitor, with a IC50 ≤ 0.08 μM against human KDM4A-D and a Kᵢ of 0.52 μM against human KDM4C. Zavondemstat induces cell apoptosis, causes S-phase cell cycle arrest, reduces the population of tumor-initiating cells and inhibits cancer cell proliferation. Zavondemstat suppresses tumor growth and induces tumor regression in mouse xenograft models. Zavondemstat can be used for the research of various cancers including colorectal cancer, esophageal squamous cell carcinoma and triple-negative breast cancer .
    Zavondemstat
  • HY-110154

    Histone Demethylase Cancer
    NSC636819 is a competitive and selective inhibitor of KDM4A/KDM4B. KDM4A/KDM4B are potential progression factors for prostate cancer. NSC636819 has the potential for the research of cancer diseases, especially prostate cancer .
    NSC636819
  • HY-RS07214

    Small Interfering RNA (siRNA) Others

    KDM4B Human Pre-designed siRNA Set A contains three designed siRNAs for KDM4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    KDM4B Human Pre-designed siRNA Set A
    KDM4B Human Pre-designed siRNA Set A
  • HY-RS23577

    Small Interfering RNA (siRNA) Others

    Kdm4b Rat Pre-designed siRNA Set A contains three designed siRNAs for Kdm4b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Kdm4b Rat Pre-designed siRNA Set A
    Kdm4b Rat Pre-designed siRNA Set A
  • HY-RS17132

    Small Interfering RNA (siRNA) Others

    Kdm4b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kdm4b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Kdm4b Mouse Pre-designed siRNA Set A
    Kdm4b Mouse Pre-designed siRNA Set A
  • HY-101799R

    KDM4B Inhibitor B3 (Standard)

    Reference Standards Histone Demethylase Cancer
    NCGC00244536 (Standard) (KDM4B Inhibitor B3 (Standard)) is the analytical standard of NCGC00244536 (HY-101799). This product is intended for research and analytical applications. NCGC00244536 is a potent KDM4B inhibitor with an IC50 of 10 nM.
    NCGC00244536 (Standard)
  • HY-173135

    PROTACs Histone Demethylase Apoptosis Cancer
    PROTAC KDM4 degrader-1 is a KDM4 PROTAC degrader that degrades KDM4A-C with DC50 values of 37.53, 39.93, and 49.41 nM, respectively, while sparing KDM4D. PROTAC KDM4 degrader-1 induces cell cycle arrest, apoptosis and antiproliferative activity in esophageal cancer cells. PROTAC KDM4 degrader-1 can be used for the research of esophageal cancer .
    PROTAC KDM4 degrader-1
  • HY-104048R

    Reference Standards Histone Demethylase Cancer
    QC6352 (Standard) is the analytical standard of QC6352 (HY-104048). This product is intended for research and analytical applications. QC6352 is an orally active KDM4 inhibitor with anti-tumor and anti-proliferative activity. QC6352 has in vivo inhibitory effects on PDX models of breast and colon cancer and reduces the number of chemoresistant cell populations. QC6352 inhibits KDM4 different isoforms with IC50s of 104 nM (KDM4A), 56 nM (KDM4B), 35 nM (KDM4C), and 104 nM (KDM4D), respectively. QC6352 has moderate inhibitory activity against KDM5 with an IC50 of 750 nM (KDM5B) .
    QC6352 (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: